Skip to content
Screener

Solesence, Inc. SLSN Q3 2025 earnings

Reported November 11, 2025 · Before market open

Revenue$14.6M
EPS-$0.02

Next report

Nov 16, 2026 (in 3 months)

Financials

Q3 2025

Income statement

See full
Revenue$14.6M-13.5%
Gross profit$3.4M-44.8%
Operating income-$781.0K-124%
Net income-$1.1M-137%
EPS (diluted)-$0.02-150%

Balance sheet

See full
Cash & equivalents$429.0K-85.3%
Total debt$10.4M-0.7%
Total equity$17.2M+13.6%
Total assets$54.0M+12.4%

Cash flow

See full
Operating cash flow-$2.5M-160%
CapEx$418.0K-70.2%
Free cash flow-$2.9M—

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$226.95M—
Enterprise value$236.89M—
P/S3.7×—

Profitability

See full
Gross margin25.7%-3.4pp
Operating margin3.1%-4.1pp
FCF margin-20.1%—

Returns & leverage

See full
Debt / equity0.6×-0.1×
Current ratio1.8×+0.6×

Segments

By product

See full
Consumer Products$13.9M—
Personal Care Ingredients$384.0K—
Advanced Materials$270.0K—

By geography

See full
Non Us$1.7M+125%

FAQ

When did Solesence, Inc. report Q3 2025 earnings?
Solesence, Inc. (SLSN) reported Q3 2025 earnings on November 11, 2025 before market open.
What were Solesence, Inc.'s Q3 2025 revenue and EPS?
Solesence, Inc. reported revenue of $14.6M and eps of $-0.02 for Q3 2025.
How did Solesence, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 13.5% from $16.9M a year earlier.
Where can I find Solesence, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001171843-25-007246) and the 10-Q periodic report (0001999371-25-017415) directly on SEC EDGAR. The filing index links above go to sec.gov.